Urovant Sciences Ltd. Rings the Opening Bell

ABOUT THIS EVENT

Urovant Sciences Ltd. (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, Keith Katkin, CEO, rang the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore